Firms

Newpath Partners

Founded
—
Type
Venture capital

Funds0

No funds on record yet.

Team

No team members on record yet.

Co-investing

ARCH Venture Partners
Alexandria Venture Investments
8VC
Moore Strategic Ventures
Bristol Myers Squibb

Investments

$122M2026-05-14Create MedicinesARCH Venture Partners, 8VC, Alexandria Venture Investments, Newpath Partners
$122M2026Create MedicinesARCH Venture Partners, 8VC, Alexandria Venture Investments, Newpath Partners
$100M2024-07-23AutobahnARCH Venture Partners, Canaan Partners, Insight Partners, Newpath Partners, Bristol Myers Squibb, Monograph Capital
$100M2024-07-23Autobahn TherapeuticsARCH Venture Partners, Canaan Partners, Insight Partners, Newpath Partners, Bristol Myers Squibb, Monograph Capital
$50M2023-09-19Magnet BiomedicineARCH Venture Partners, Newpath Partners
$73M2023-05-18Myeloid TherapeuticsARCH Venture Partners, 8VC, Alexandria Venture Investments, Moore Strategic Ventures, Primary Venture Partners, Newpath Partners
$270M2023-04-26Orbital TherapeuticsARCH Venture Partners, Casdin Capital, Alexandria Venture Investments, Andreessen Horowitz, Moore Strategic Ventures, Newpath Partners, Vineeta Agarwala
$200M2021-07-13Prime Medicine, Inc.ARCH Venture Partners, F-Prime Capital, GV, Newpath Partners, Casdin Capital, Cormorant Asset Management, Moore Strategic Ventures, PSP Investments, Redmile Group, Samsara BioCapital, T. Rowe Price Associates
$—Unknown datePrime Medicine, Inc.ARCH Venture Partners, F-Prime Capital, GV, Newpath Partners, Samsara BioCapital